Toxic Epidermal Necrolysis-Like Reaction Following Combination Therapy With Camrelizumab and Apatinib for Advanced Gallbladder Carcinoma

Yonghao Yang(Army Medical University), Zibing Wang(Huazhong University of Science and Technology), Bicheng Zhang(University of Electronic Science and Technology of China), Brian G. Till(University of Washington), Tiepeng Li(East China Normal University), Hongle Li(Shanghai Jiao Tong University), Jun Wang(South China Agricultural University), Jun Li(Sun Yat-sen University), Hao Huang(Air Force Medical University), Quanli Gao(Zhengzhou University), Hanping Wang(Chinese Academy of Medical Sciences & Peking Union Medical College)
Frontiers in Oncology
October 29, 2021
10.3389/fonc.2021.728253
Cited by 4

Related Papers

Graphene and graphene oxide: biofunctionalization and applications in biotechnology
|Trends in biotechnology|2011|1.5k
Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells
|Blood|2008|719
Clinical characteristics of 82 cases of death from COVID-19
|PLoS ONE|2020|594
CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results
|Blood|2012|530
Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19
|Frontiers in Molecular Biosciences|2020|497